Neuroanesthesia — MCQs

Q: Which is the inhalation agent of choice in a patient with raised intracranial pressure?

Isoflurane. **Explanation:** The primary goal in neuroanesthesia for patients with raised intracranial pressure (ICP) is to maintain cerebral perfusion pressure (CPP) while preventing further increases in ICP. **Why Isoflurane is the Correct Answer:** Isoflurane is considered the volatile anesthetic of choice for neurosurgery because it provides a favorable balance between cerebral metabolic rate (CMRO2) reduction and cerebral vasodilation. At doses below 1 MAC, Isoflurane significantly reduces CMRO2 (neuroprotection) while causing minimal cerebral vasodilation. Any potential increase in ICP due to vasodilation can be easily blunted by inducing **mild hypocapnia (hyperventilation)**. Furthermore, it preserves cerebral autoregulation better than older agents. **Analysis of Incorrect Options:** * **Halothane:** This is the most potent cerebral vasodilator among all inhalational agents. It significantly increases cerebral blood volume and ICP, making it contraindicated in patients with space-occupying lesions. * **Enflurane:** It is avoided in neurosurgery because it can induce **seizure-like activity** on EEG, especially under conditions of hypocapnia, which increases cerebral oxygen demand. * **Sevoflurane:** While also used in neuroanesthesia, it is generally considered second to Isoflurane because, at higher concentrations (>1.5 MAC), it may impair cerebral autoregulation more than Isoflurane. **High-Yield Clinical Pearls for NEET-PG:** * **Order of Vasodilation (ICP Increase):** Halothane > Enflurane > Isoflurane = Sevoflurane = Desflurane. * **Order of CMRO2 Suppression:** Isoflurane is the most potent at suppressing metabolic rate. * **Intravenous Agent of Choice:** **Propofol** is the preferred IV induction agent as it reduces both CMRO2 and ICP (cerebral vasoconstrictor). * **Nitrous Oxide (N2O):** Should be avoided as it increases ICP and can expand a pneumocephalus.

Q: An unconscious patient with a head injury presents to the casualty department and shows signs of raised intracranial pressure on examination. Which anesthetic agent is contraindicated in this scenario?

Ketamine. **Explanation:** In patients with head injuries and raised intracranial pressure (ICP), the primary goal of anesthetic management is to maintain cerebral perfusion pressure (CPP) while avoiding agents that further increase ICP. **Why Ketamine is the Correct Answer:** Ketamine is traditionally **contraindicated** in patients with raised ICP because it is a potent cerebral vasodilator. By increasing cerebral blood flow (CBF) and cerebral metabolic rate of oxygen ($CMRO_2$), it leads to an increase in intracranial volume and a subsequent rise in ICP. In a non-compliant skull (due to trauma or edema), this can trigger brain herniation. Additionally, Ketamine can interfere with the drainage of cerebrospinal fluid (CSF). **Analysis of Incorrect Options:** * **Thiopentone (Option A):** This is often the drug of choice for neuroprotection. It causes cerebral vasoconstriction, decreases CBF, and significantly reduces $CMRO_2$, thereby lowering ICP. * **Propofol (Option B):** Similar to Thiopentone, Propofol reduces $CMRO_2$, CBF, and ICP. It is frequently used for induction and maintenance (TIVA) in neurosurgery. * **Etomidate (Option D):** Etomidate provides hemodynamic stability while decreasing CBF and ICP. It is useful in head injury patients who are also hemodynamically unstable (hypovolemic). **High-Yield Clinical Pearls for NEET-PG:** 1. **CPP Formula:** $CPP = MAP - ICP$. Agents that decrease ICP help maintain CPP. 2. **The "Ideal" Neuro-induction Agent:** Thiopentone is the gold standard for "brain shrinkage." 3. **Exception for Ketamine:** Recent studies suggest Ketamine may be used if the patient is on controlled ventilation (preventing $CO_2$ rise), but for exam purposes, it remains the classic contraindicated agent for raised ICP. 4. **Inhalational Agents:** Nitrous Oxide ($N_2O$) also increases ICP and is generally avoided in neurotrauma.

Q: Which of the following drugs cannot reduce the cerebrospinal fluid (CSF) pressure?

Ketamine. **Explanation:** The primary determinant of intracranial pressure (ICP) and cerebrospinal fluid (CSF) pressure is the balance between cerebral blood flow (CBF), CSF production, and CSF drainage. **Why Ketamine is the correct answer:** Ketamine is a potent **cerebral vasodilator**. By increasing cerebral blood flow and cerebral blood volume, it leads to a significant **increase in intracranial pressure (ICP)** and CSF pressure. Additionally, it can interfere with the reabsorption of CSF. Therefore, it is traditionally contraindicated in patients with space-occupying lesions or head injuries where intracranial compliance is compromised. **Why the other options are incorrect:** * **Acetazolamide:** A carbonic anhydrase inhibitor that directly **decreases CSF production** (by up to 50%) at the choroid plexus, thereby reducing CSF pressure. * **20% Mannitol:** An osmotic diuretic that creates an osmotic gradient, drawing fluid out of the brain parenchyma into the intravascular space. It also reduces CSF production, effectively **lowering ICP**. * **Thiopentone:** A barbiturate that causes potent cerebral vasoconstriction (decreased CBF) and reduces cerebral metabolic rate ($CMRO_2$). This "coupled" reduction leads to a significant **decrease in ICP** and CSF pressure. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice for Induction in Head Injury:** Etomidate or Thiopentone (if hemodynamically stable) are preferred as they reduce ICP. * **Inhalational Anesthetics:** All volatile agents (Halothane > Isoflurane) cause vasodilation and increase ICP; however, **Sevoflurane** is often preferred in neurosurgery due to its minimal effect on autoregulation at low doses. * **Exceptions for Ketamine:** Recent studies suggest that if the patient is well-ventilated (preventing hypercapnia) and co-administered with benzodiazepines, the ICP rise may be attenuated, but for exam purposes, it remains the classic drug that **increases ICP**.

Q: A 10°C decrease in temperature causes a decrease in cerebral metabolic rate by approximately what percentage?

70%. **Explanation:** The relationship between temperature and the Cerebral Metabolic Rate of Oxygen consumption ($CMRO_2$) is defined by the **$Q_{10}$ effect**. In the brain, the $Q_{10}$ value is approximately **2 to 3**, meaning that for every 10°C change in temperature, the metabolic rate changes by a factor of two to three. Specifically, for every **1°C decrease** in body temperature, there is a **6–7% reduction** in $CMRO_2$. Therefore, a **10°C decrease** results in a cumulative reduction of approximately **50% to 70%**. This profound reduction in metabolic demand is the physiological basis for using induced hypothermia during neurosurgery and post-cardiac arrest to provide neuroprotection against ischemic injury. **Analysis of Options:** * **Option A (10%):** This is too low; a 10% reduction occurs with a mere 1.5°C drop. * **Option B (30%):** This corresponds to a temperature drop of roughly 4–5°C. * **Option C (50%):** While 50% is the lower end of the $Q_{10}$ range, **70%** is the more accurate physiological maximum cited in standard anesthesia textbooks (like Miller’s) for a full 10°C drop. * **Option D (70%):** Correct. It reflects the significant exponential drop in enzymatic activity and neuronal firing at lower temperatures. **High-Yield Clinical Pearls for NEET-PG:** * **Burst Suppression:** Hypothermia can decrease $CMRO_2$ until the EEG becomes isoelectric (usually around 18–20°C). * **Coupling:** Under normal conditions, Cerebral Blood Flow (CBF) remains "coupled" to $CMRO_2$; thus, hypothermia also causes a proportional decrease in CBF, which helps reduce intracranial pressure (ICP). * **Hyperthermia:** Conversely, fever increases $CMRO_2$ and can exacerbate secondary brain injury. For every 1°C increase, $CMRO_2$ increases by ~7%.

Q: Which anesthetic agent is safe to use in a patient with increased intracranial pressure (ICP)?

Thiopentone. ### Explanation **Correct Answer: B. Thiopentone** **Why Thiopentone is correct:** Thiopentone (a barbiturate) is considered a "brain-protective" agent and is a gold standard for induction in patients with raised intracranial pressure (ICP). It works by causing **cerebral vasoconstriction**, which leads to a significant reduction in **Cerebral Blood Flow (CBF)** and **Cerebral Blood Volume (CBV)**. Consequently, this lowers the ICP. Additionally, it reduces the **Cerebral Metabolic Rate of Oxygen (CMRO2)**, protecting the brain from ischemic injury. **Why the other options are incorrect:** * **Halothane:** All volatile inhalational anesthetics are potent **cerebral vasodilators**. Halothane is the most potent vasodilator among them; it increases CBF and CBV, which significantly exacerbates intracranial hypertension. * **Ketamine:** Traditionally, Ketamine is contraindicated in head injuries because it acts as a cerebral vasodilator, increasing CBF, CMRO2, and potentially ICP (though recent evidence suggests this is minimal under controlled ventilation, it remains the "classic" wrong answer for exams). * **Ether:** Similar to halothane, ether causes significant cerebral vasodilation and increases ICP, making it unsafe for neurosurgery. **High-Yield Clinical Pearls for NEET-PG:** * **The Inverse Steal Phenomenon (Robin Hood Effect):** Thiopentone constricts vessels in healthy brain tissue, diverting blood flow toward ischemic areas where vessels are already maximally dilated. * **Drug of Choice for ICP:** While Thiopentone is the classic answer, **Propofol** is also commonly used as it similarly reduces CMRO2 and ICP. * **Etomidate:** Useful in neuro-patients with hemodynamic instability as it lowers ICP while maintaining stable blood pressure. * **Avoid Succinylcholine:** It can cause a transient rise in ICP; if used, ensure a deep plane of anesthesia or prior administration of a non-depolarizing muscle relaxant.

Q: Which of the following intravenous anesthetics causes an increase in cerebral oxygen tension?

Ketamine. ### Explanation The correct answer is **Ketamine**. **1. Why Ketamine is Correct:** Most intravenous anesthetics are "cerebro-protective" because they decrease the Cerebral Metabolic Rate of Oxygen consumption ($CMRO_2$) and Cerebral Blood Flow (CBF). **Ketamine is the notable exception.** It acts as a potent cerebral vasodilator, significantly increasing CBF and cerebral blood volume. Because the increase in oxygen delivery (via increased blood flow) outweighs the modest increase in $CMRO_2$, it results in an overall **increase in cerebral oxygen tension ($PbtO_2$)**. **2. Why the Other Options are Incorrect:** * **Thiopentone & Propofol:** These agents cause **"Cerebral Metabolic Coupling."** They decrease $CMRO_2$ (by suppressing neuronal activity), which leads to secondary cerebral vasoconstriction and a decrease in CBF. This reduces intracranial pressure (ICP) and cerebral oxygen tension. * **Etomidate:** Similar to barbiturates, etomidate is a potent cerebral vasoconstrictor that decreases both $CMRO_2$ and CBF, making it useful for maintaining hemodynamic stability in neurosurgical patients. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "Inverse" Rule:** While most IV agents decrease CBF/ICP, Ketamine **increases** them. Conversely, while most inhalational agents increase CBF, Nitrous Oxide is the most potent vasodilator among them. * **Clinical Contraindication:** Traditionally, Ketamine was strictly avoided in patients with space-occupying lesions or increased ICP. However, recent evidence suggests it may be used if the patient is ventilated and co-administered with benzodiazepines or propofol. * **Drug of Choice:** **Propofol** is currently the preferred agent for neuro-induction due to its rapid recovery and effective reduction of ICP.

Neuroanesthesia Indian Medical PG Practice Questions and MCQs

Question 1: Which is the inhalation agent of choice in a patient with raised intracranial pressure?

A. Isoflurane (Correct Answer)
B. Enflurane
C. Sevoflurane
D. Halothane

Explanation: **Explanation:** The primary goal in neuroanesthesia for patients with raised intracranial pressure (ICP) is to maintain cerebral perfusion pressure (CPP) while preventing further increases in ICP. **Why Isoflurane is the Correct Answer:** Isoflurane is considered the volatile anesthetic of choice for neurosurgery because it provides a favorable balance between cerebral metabolic rate (CMRO2) reduction and cerebral vasodilation. At doses below 1 MAC, Isoflurane significantly reduces CMRO2 (neuroprotection) while causing minimal cerebral vasodilation. Any potential increase in ICP due to vasodilation can be easily blunted by inducing **mild hypocapnia (hyperventilation)**. Furthermore, it preserves cerebral autoregulation better than older agents. **Analysis of Incorrect Options:** * **Halothane:** This is the most potent cerebral vasodilator among all inhalational agents. It significantly increases cerebral blood volume and ICP, making it contraindicated in patients with space-occupying lesions. * **Enflurane:** It is avoided in neurosurgery because it can induce **seizure-like activity** on EEG, especially under conditions of hypocapnia, which increases cerebral oxygen demand. * **Sevoflurane:** While also used in neuroanesthesia, it is generally considered second to Isoflurane because, at higher concentrations (>1.5 MAC), it may impair cerebral autoregulation more than Isoflurane. **High-Yield Clinical Pearls for NEET-PG:** * **Order of Vasodilation (ICP Increase):** Halothane > Enflurane > Isoflurane = Sevoflurane = Desflurane. * **Order of CMRO2 Suppression:** Isoflurane is the most potent at suppressing metabolic rate. * **Intravenous Agent of Choice:** **Propofol** is the preferred IV induction agent as it reduces both CMRO2 and ICP (cerebral vasoconstrictor). * **Nitrous Oxide (N2O):** Should be avoided as it increases ICP and can expand a pneumocephalus.

Question 2: Intracranial pressure (ICP) is raised due to:

A. Ketamine (Correct Answer)
B. Scoline
C. Halothane
D. Ether

Explanation: ### Explanation **Correct Answer: A. Ketamine** **Mechanism of Action:** Ketamine is a dissociative anesthetic that acts as an NMDA receptor antagonist. Unlike most other induction agents, Ketamine is a potent **cerebral vasodilator**. It increases Cerebral Blood Flow (CBF) and Cerebral Metabolic Rate of Oxygen ($CMRO_2$), which leads to a significant **increase in Intracranial Pressure (ICP)**. Consequently, it is generally contraindicated in patients with space-occupying lesions, head injuries, or intracranial hypertension. **Analysis of Other Options:** * **B. Scoline (Succinylcholine):** While Succinylcholine can cause a transient, mild increase in ICP (likely due to muscle fasciculations and increased CVP), it is **not** the primary answer in this context. In modern neuroanesthesia, its benefits for rapid sequence induction often outweigh this minor risk, and the effect can be blunted with defasciculating doses of non-depolarizers. * **C. Halothane:** Halothane is a potent vasodilator and can increase ICP; however, in the hierarchy of "ICP-elevating drugs" for exam purposes, Ketamine is the classic "high-yield" answer due to its profound effect on cerebral hemodynamics. * **D. Ether:** While Ether causes some vasodilation, it is obsolete in modern practice and less potent in its ICP-elevating effects compared to Ketamine. **High-Yield Clinical Pearls for NEET-PG:** * **The "Neuro-Friendly" Induction Agent:** **Thiopentone** (and Propofol) are the drugs of choice for neurosurgery as they decrease $CMRO_2$, CBF, and ICP (cerebral protection). * **Exceptions for Ketamine:** Recent studies suggest that if a patient is well-ventilated (normocapnia maintained), the ICP increase from Ketamine may be minimal, but for MCQ purposes, **Ketamine = Increased ICP**. * **Inhalational Agents:** All volatile anesthetics cause vasodilation at >1 MAC, but **Sevoflurane** is preferred over Halothane in neurosurgery because it has the least effect on cerebral autoregulation.

Question 3: An unconscious patient with a head injury presents to the casualty department and shows signs of raised intracranial pressure on examination. Which anesthetic agent is contraindicated in this scenario?

A. Thiopentone
B. Propofol
C. Ketamine (Correct Answer)
D. Etomidate

Explanation: **Explanation:** In patients with head injuries and raised intracranial pressure (ICP), the primary goal of anesthetic management is to maintain cerebral perfusion pressure (CPP) while avoiding agents that further increase ICP. **Why Ketamine is the Correct Answer:** Ketamine is traditionally **contraindicated** in patients with raised ICP because it is a potent cerebral vasodilator. By increasing cerebral blood flow (CBF) and cerebral metabolic rate of oxygen ($CMRO_2$), it leads to an increase in intracranial volume and a subsequent rise in ICP. In a non-compliant skull (due to trauma or edema), this can trigger brain herniation. Additionally, Ketamine can interfere with the drainage of cerebrospinal fluid (CSF). **Analysis of Incorrect Options:** * **Thiopentone (Option A):** This is often the drug of choice for neuroprotection. It causes cerebral vasoconstriction, decreases CBF, and significantly reduces $CMRO_2$, thereby lowering ICP. * **Propofol (Option B):** Similar to Thiopentone, Propofol reduces $CMRO_2$, CBF, and ICP. It is frequently used for induction and maintenance (TIVA) in neurosurgery. * **Etomidate (Option D):** Etomidate provides hemodynamic stability while decreasing CBF and ICP. It is useful in head injury patients who are also hemodynamically unstable (hypovolemic). **High-Yield Clinical Pearls for NEET-PG:** 1. **CPP Formula:** $CPP = MAP - ICP$. Agents that decrease ICP help maintain CPP. 2. **The "Ideal" Neuro-induction Agent:** Thiopentone is the gold standard for "brain shrinkage." 3. **Exception for Ketamine:** Recent studies suggest Ketamine may be used if the patient is on controlled ventilation (preventing $CO_2$ rise), but for exam purposes, it remains the classic contraindicated agent for raised ICP. 4. **Inhalational Agents:** Nitrous Oxide ($N_2O$) also increases ICP and is generally avoided in neurotrauma.

Question 4: Which of the following drugs cannot reduce the cerebrospinal fluid (CSF) pressure?

A. Acetazolamide
B. 20% Mannitol
C. Ketamine (Correct Answer)
D. Thiopentone

Explanation: **Explanation:** The primary determinant of intracranial pressure (ICP) and cerebrospinal fluid (CSF) pressure is the balance between cerebral blood flow (CBF), CSF production, and CSF drainage. **Why Ketamine is the correct answer:** Ketamine is a potent **cerebral vasodilator**. By increasing cerebral blood flow and cerebral blood volume, it leads to a significant **increase in intracranial pressure (ICP)** and CSF pressure. Additionally, it can interfere with the reabsorption of CSF. Therefore, it is traditionally contraindicated in patients with space-occupying lesions or head injuries where intracranial compliance is compromised. **Why the other options are incorrect:** * **Acetazolamide:** A carbonic anhydrase inhibitor that directly **decreases CSF production** (by up to 50%) at the choroid plexus, thereby reducing CSF pressure. * **20% Mannitol:** An osmotic diuretic that creates an osmotic gradient, drawing fluid out of the brain parenchyma into the intravascular space. It also reduces CSF production, effectively **lowering ICP**. * **Thiopentone:** A barbiturate that causes potent cerebral vasoconstriction (decreased CBF) and reduces cerebral metabolic rate ($CMRO_2$). This "coupled" reduction leads to a significant **decrease in ICP** and CSF pressure. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice for Induction in Head Injury:** Etomidate or Thiopentone (if hemodynamically stable) are preferred as they reduce ICP. * **Inhalational Anesthetics:** All volatile agents (Halothane > Isoflurane) cause vasodilation and increase ICP; however, **Sevoflurane** is often preferred in neurosurgery due to its minimal effect on autoregulation at low doses. * **Exceptions for Ketamine:** Recent studies suggest that if the patient is well-ventilated (preventing hypercapnia) and co-administered with benzodiazepines, the ICP rise may be attenuated, but for exam purposes, it remains the classic drug that **increases ICP**.

Question 5: ICT is caused by which of the following agents?

A. Ketamine (Correct Answer)
B. Thiopentane
C. Halothane
D. Propofol

Explanation: **Explanation:** The correct answer is **Ketamine**. **Why Ketamine is correct:** Ketamine is a unique intravenous anesthetic agent that acts as an NMDA receptor antagonist. Unlike most other induction agents, Ketamine is a potent **cerebral vasodilator**. By increasing cerebral blood flow (CBF), it leads to an increase in cerebral blood volume, which subsequently results in an **elevation of Intracranial Tension (ICT)**. Consequently, Ketamine is generally contraindicated in patients with space-occupying lesions, head injuries, or any condition where intracranial pressure is already compromised. **Why the other options are incorrect:** * **Thiopentone (Thiopentane):** This is a barbiturate that causes potent cerebral vasoconstriction. It reduces CBF and cerebral metabolic rate ($CMRO_2$), thereby **decreasing ICT**. It is often used for "brain protection." * **Propofol:** Similar to barbiturates, Propofol reduces $CMRO_2$ and causes cerebral vasoconstriction, leading to a **decrease in ICT**. It is the preferred agent for total intravenous anesthesia (TIVA) in neurosurgery. * **Halothane:** While volatile anesthetics can increase ICT via vasodilation, the question asks for the agent most classically associated with this side effect among the given choices. In modern practice, Ketamine's effect on ICT is a more frequently tested "absolute" contraindication in neuro-anesthesia compared to the dose-dependent effects of Halothane. **High-Yield Clinical Pearls for NEET-PG:** * **The "Neuro-Friendly" Rule:** Most IV anesthetics (Thiopentone, Propofol, Etomidate) *decrease* ICT. **Ketamine is the notable exception.** * **Inhalational Agents:** All volatile agents (Halothane > Isoflurane > Sevoflurane) cause vasodilation and can increase ICT, especially at concentrations >1 MAC. * **Ketamine Exceptions:** Recent studies suggest that if a patient is well-ventilated (preventing hypercapnia) and co-administered with benzodiazepines, the ICT rise from Ketamine may be blunted, but for exam purposes, it remains the agent that **increases ICT**.

Question 6: A 10°C decrease in temperature causes a decrease in cerebral metabolic rate by approximately what percentage?

A. 10%
B. 30%
C. 50%
D. 70% (Correct Answer)

Explanation: **Explanation:** The relationship between temperature and the Cerebral Metabolic Rate of Oxygen consumption ($CMRO_2$) is defined by the **$Q_{10}$ effect**. In the brain, the $Q_{10}$ value is approximately **2 to 3**, meaning that for every 10°C change in temperature, the metabolic rate changes by a factor of two to three. Specifically, for every **1°C decrease** in body temperature, there is a **6–7% reduction** in $CMRO_2$. Therefore, a **10°C decrease** results in a cumulative reduction of approximately **50% to 70%**. This profound reduction in metabolic demand is the physiological basis for using induced hypothermia during neurosurgery and post-cardiac arrest to provide neuroprotection against ischemic injury. **Analysis of Options:** * **Option A (10%):** This is too low; a 10% reduction occurs with a mere 1.5°C drop. * **Option B (30%):** This corresponds to a temperature drop of roughly 4–5°C. * **Option C (50%):** While 50% is the lower end of the $Q_{10}$ range, **70%** is the more accurate physiological maximum cited in standard anesthesia textbooks (like Miller’s) for a full 10°C drop. * **Option D (70%):** Correct. It reflects the significant exponential drop in enzymatic activity and neuronal firing at lower temperatures. **High-Yield Clinical Pearls for NEET-PG:** * **Burst Suppression:** Hypothermia can decrease $CMRO_2$ until the EEG becomes isoelectric (usually around 18–20°C). * **Coupling:** Under normal conditions, Cerebral Blood Flow (CBF) remains "coupled" to $CMRO_2$; thus, hypothermia also causes a proportional decrease in CBF, which helps reduce intracranial pressure (ICP). * **Hyperthermia:** Conversely, fever increases $CMRO_2$ and can exacerbate secondary brain injury. For every 1°C increase, $CMRO_2$ increases by ~7%.

Question 7: Triple H therapy for subarachnoid hemorrhage consists of all the following except?

A. Hypertension
B. Hypervolemia
C. Hemodilution
D. Hypothermia (Correct Answer)

Explanation: **Explanation:** Triple H therapy is a traditional management strategy used to prevent and treat **Delayed Cerebral Ischemia (DCI)** resulting from cerebral vasospasm, which typically occurs 3–14 days after a subarachnoid hemorrhage (SAH). The primary goal is to maintain cerebral perfusion pressure (CPP) in areas where autoregulation is impaired. **Why Hypothermia is the correct answer:** **Hypothermia (Option D)** is not a component of Triple H therapy. While therapeutic hypothermia has been studied for neuroprotection, it is not part of the standard hemodynamic augmentation protocol for vasospasm and can actually lead to complications like coagulopathy and arrhythmias. **Analysis of the "Triple H" components:** * **Hypertension (Option A):** This is the most critical component. By increasing the Mean Arterial Pressure (MAP) using vasopressors (like norepinephrine), blood is forced through narrowed spastic vessels to maintain brain oxygenation. * **Hypervolemia (Option B):** Achieved through aggressive IV fluid administration to ensure adequate cardiac output. However, modern practice is shifting toward "Euvolemia" to avoid pulmonary edema. * **Hemodilution (Option C):** By slightly lowering the hematocrit (target ~30–33%), blood viscosity decreases. This improves microcirculatory flow (rheology) through the constricted cerebral arteries. **Clinical Pearls for NEET-PG:** * **Current Trend:** Modern guidelines now emphasize **"Induced Hypertension"** over the full Triple H, as hypervolemia and hemodilution often increase complications without significantly improving outcomes. * **Gold Standard Diagnosis:** Digital Subtraction Angiography (DSA) is the gold standard for detecting vasospasm, while Transcranial Doppler (TCD) is used for bedside monitoring. * **Drug of Choice:** **Nimodipine** (a calcium channel blocker) is given to all SAH patients to improve neurological outcomes, though it does not significantly reduce the incidence of radiologic vasospasm.

Question 8: Which anesthetic agent is safe to use in a patient with increased intracranial pressure (ICP)?

A. Halothane
B. Thiopentone (Correct Answer)
C. Ketamine
D. Ether

Explanation: ### Explanation **Correct Answer: B. Thiopentone** **Why Thiopentone is correct:** Thiopentone (a barbiturate) is considered a "brain-protective" agent and is a gold standard for induction in patients with raised intracranial pressure (ICP). It works by causing **cerebral vasoconstriction**, which leads to a significant reduction in **Cerebral Blood Flow (CBF)** and **Cerebral Blood Volume (CBV)**. Consequently, this lowers the ICP. Additionally, it reduces the **Cerebral Metabolic Rate of Oxygen (CMRO2)**, protecting the brain from ischemic injury. **Why the other options are incorrect:** * **Halothane:** All volatile inhalational anesthetics are potent **cerebral vasodilators**. Halothane is the most potent vasodilator among them; it increases CBF and CBV, which significantly exacerbates intracranial hypertension. * **Ketamine:** Traditionally, Ketamine is contraindicated in head injuries because it acts as a cerebral vasodilator, increasing CBF, CMRO2, and potentially ICP (though recent evidence suggests this is minimal under controlled ventilation, it remains the "classic" wrong answer for exams). * **Ether:** Similar to halothane, ether causes significant cerebral vasodilation and increases ICP, making it unsafe for neurosurgery. **High-Yield Clinical Pearls for NEET-PG:** * **The Inverse Steal Phenomenon (Robin Hood Effect):** Thiopentone constricts vessels in healthy brain tissue, diverting blood flow toward ischemic areas where vessels are already maximally dilated. * **Drug of Choice for ICP:** While Thiopentone is the classic answer, **Propofol** is also commonly used as it similarly reduces CMRO2 and ICP. * **Etomidate:** Useful in neuro-patients with hemodynamic instability as it lowers ICP while maintaining stable blood pressure. * **Avoid Succinylcholine:** It can cause a transient rise in ICP; if used, ensure a deep plane of anesthesia or prior administration of a non-depolarizing muscle relaxant.

Question 9: Which of the following intravenous anesthetics causes an increase in cerebral oxygen tension?

A. Thiopentone
B. Propofol
C. Ketamine (Correct Answer)
D. Etomidate

Explanation: ### Explanation The correct answer is **Ketamine**. **1. Why Ketamine is Correct:** Most intravenous anesthetics are "cerebro-protective" because they decrease the Cerebral Metabolic Rate of Oxygen consumption ($CMRO_2$) and Cerebral Blood Flow (CBF). **Ketamine is the notable exception.** It acts as a potent cerebral vasodilator, significantly increasing CBF and cerebral blood volume. Because the increase in oxygen delivery (via increased blood flow) outweighs the modest increase in $CMRO_2$, it results in an overall **increase in cerebral oxygen tension ($PbtO_2$)**. **2. Why the Other Options are Incorrect:** * **Thiopentone & Propofol:** These agents cause **"Cerebral Metabolic Coupling."** They decrease $CMRO_2$ (by suppressing neuronal activity), which leads to secondary cerebral vasoconstriction and a decrease in CBF. This reduces intracranial pressure (ICP) and cerebral oxygen tension. * **Etomidate:** Similar to barbiturates, etomidate is a potent cerebral vasoconstrictor that decreases both $CMRO_2$ and CBF, making it useful for maintaining hemodynamic stability in neurosurgical patients. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "Inverse" Rule:** While most IV agents decrease CBF/ICP, Ketamine **increases** them. Conversely, while most inhalational agents increase CBF, Nitrous Oxide is the most potent vasodilator among them. * **Clinical Contraindication:** Traditionally, Ketamine was strictly avoided in patients with space-occupying lesions or increased ICP. However, recent evidence suggests it may be used if the patient is ventilated and co-administered with benzodiazepines or propofol. * **Drug of Choice:** **Propofol** is currently the preferred agent for neuro-induction due to its rapid recovery and effective reduction of ICP.

Question 10: Which intravenous anesthetic drug does not induce cerebral metabolism?

A. Thiopentone (Correct Answer)
B. Ketamine
C. Propofol
D. Methohexitone

Explanation: ### Explanation The primary goal in neuroanesthesia is to maintain a balance between **Cerebral Metabolic Rate of Oxygen (CMRO2)** and **Cerebral Blood Flow (CBF)**. Most intravenous anesthetics produce "cerebral metabolic coupling," where a decrease in metabolic demand leads to a proportional decrease in blood flow and intracranial pressure (ICP). **Why Thiopentone is Correct:** **Thiopentone (Option A)** is the gold standard for inducing a dose-dependent reduction in CMRO2. It suppresses neuronal activity until the EEG becomes isoelectric, at which point CMRO2 is reduced by approximately 50%. This reduction leads to cerebral vasoconstriction, decreased CBF, and decreased ICP, making it highly neuroprotective during focal cerebral ischemia. **Analysis of Incorrect Options:** * **Ketamine (Option B):** Unlike other IV agents, Ketamine is a potent cerebral vasodilator. It **increases** CMRO2, CBF, and ICP. It is generally avoided in patients with space-occupying lesions or intracranial hypertension. * **Propofol (Option C):** While Propofol *does* reduce CMRO2 and CBF (similar to Thiopentone), the question asks which drug does *not* induce (increase) metabolism. However, in the context of classic teaching and competitive exams, Thiopentone is the definitive answer for the "reduction" of metabolism, whereas Ketamine is the one that "induces" or increases it. *Note: If the question implies "which drug reduces metabolism," both A and C do so, but Thiopentone is the historical benchmark.* * **Methohexitone (Option D):** Although a barbiturate, it can activate epileptic foci and **increase** metabolic activity in certain brain regions. It is often used to prolong seizure duration during Electroconvulsive Therapy (ECT). **High-Yield Clinical Pearls for NEET-PG:** * **Drug of choice for ECT:** Methohexitone (due to pro-convulsant properties). * **Drug of choice for neuroprotection (focal ischemia):** Thiopentone. * **Inverse Steal Phenomenon (Robin Hood Effect):** Thiopentone shunts blood from normal brain tissue to ischemic areas by constricting vessels in healthy regions. * **Etomidate:** Also reduces CMRO2 and ICP but is associated with adrenocortical suppression.

Question 11: A 10 degree Celsius decrease in body temperature causes a decrease in cerebral metabolic rate by approximately what percentage?

A. 10%
B. 30%
C. 50%
D. 70% (Correct Answer)

Explanation: **Explanation:** The correct answer is **70% (Option D)**. This relationship is governed by the concept of **$Q_{10}$**, which represents the factor by which a metabolic rate changes with a 10°C change in temperature. 1. **Why 70% is correct:** In the human brain, the $Q_{10}$ for the Cerebral Metabolic Rate of Oxygen consumption ($CMRO_2$) is approximately **2 to 3**. This means that for every 10°C decrease in body temperature, the metabolic rate decreases by roughly 50% to 70%. Most standard anesthesia textbooks (like Miller’s) specify that $CMRO_2$ decreases by approximately **7% for every 1°C drop** in temperature. Therefore, a 10°C drop results in a cumulative decrease of roughly 70%. This profound reduction is the physiological basis for using **induced hypothermia** to provide neuroprotection during cardiac surgery or neurosurgery. 2. **Why other options are incorrect:** * **A (10%) & B (30%):** These values significantly underestimate the potent effect of temperature on enzymatic activity and neuronal firing. A 10-30% reduction would occur with only a 2-4°C drop. * **C (50%):** While $Q_{10}$ can be as low as 2 (representing a 50% drop), the clinical standard taught for exams is the more significant 7% per degree Celsius, making 70% the more accurate high-yield answer. **High-Yield Clinical Pearls for NEET-PG:** * **Linearity:** The relationship between temperature and $CMRO_2$ is linear between 27°C and 37°C. * **Burst Suppression:** At temperatures below 20°C, the EEG becomes isoelectric (flat), indicating a massive reduction in the "functional" component of cerebral metabolism. * **Coupling:** Under normal conditions, **Cerebral Blood Flow (CBF)** is "coupled" to $CMRO_2$. Therefore, as temperature drops and $CMRO_2$ decreases, CBF also decreases proportionally, which helps reduce intracranial pressure (ICP).

Question 12: Which of the following anesthetic agents leads to an increase in intracranial pressure (ICP)?

A. Thiopentone
B. Ketamine (Correct Answer)
C. Propofol
D. Sevoflurane

Explanation: **Explanation:** The primary goal in neuroanesthesia is to maintain a balance between Cerebral Blood Flow (CBF), Cerebral Metabolic Rate of Oxygen ($CMRO_2$), and Intracranial Pressure (ICP). **Why Ketamine is the Correct Answer:** Ketamine is a dissociative anesthetic that acts as a potent **cerebral vasodilator**. By increasing CBF and potentially interfering with the reabsorption of cerebrospinal fluid (CSF), it leads to a significant **increase in ICP**. Furthermore, it can cause sympathetic stimulation, leading to hypertension which further exacerbates ICP in patients with impaired autoregulation. Traditionally, it is contraindicated in patients with space-occupying lesions or head injuries. **Why the Other Options are Incorrect:** * **Thiopentone & Propofol:** Both are potent **cerebral vasoconstrictors**. They decrease CBF and $CMRO_2$ (cerebral metabolic coupling), which effectively **lowers ICP**. Thiopentone is often used for "brain protection" during focal ischemia. * **Sevoflurane:** While volatile anesthetics can cause vasodilation at higher doses (>1 MAC), at clinical concentrations (<1 MAC) and especially when combined with hyperventilation, Sevoflurane maintains stable ICP better than older agents like Halothane. It is generally considered "ICP neutral" or slightly decreasing compared to the significant rise caused by Ketamine. **High-Yield Clinical Pearls for NEET-PG:** * **The "Ideal" Neuro-induction Agent:** Propofol (decreases $CMRO_2$ and ICP). * **The "Worst" Inhalational Agent:** Halothane (causes the greatest increase in CBF/ICP). * **Cushing’s Triad:** Hypertension, Bradycardia, and Irregular Respiration (sign of increased ICP). * **Exception:** Recent studies suggest Ketamine may be used safely in neuro-patients *if* they are mechanically ventilated and co-administered with GABAergic agents (like benzodiazepines or propofol), but for exam purposes, it remains the classic agent that increases ICP.

Question 13: Which anesthetic agent is safe to use in a patient with increased intracranial pressure (ICP)?

A. Halothane
B. Thiopentone (Correct Answer)
C. Ketamine
D. Ether

Explanation: **Explanation:** The management of anesthesia in patients with increased intracranial pressure (ICP) focuses on maintaining cerebral perfusion pressure (CPP) while minimizing cerebral blood volume. **Why Thiopentone is Correct:** Thiopentone (a barbiturate) is the "gold standard" induction agent for neurosurgery. It causes **cerebral vasoconstriction**, which leads to a decrease in cerebral blood flow (CBF) and a subsequent **reduction in ICP**. Furthermore, it significantly reduces the Cerebral Metabolic Rate of Oxygen (CMRO2), providing a neuroprotective effect. This coupling of reduced metabolic demand and reduced ICP makes it ideal for patients with space-occupying lesions or head injuries. **Why the Other Options are Incorrect:** * **Halothane & Ether:** These are potent **vasodilators**. Volatile anesthetics (especially Halothane) cause cerebral vasodilation, which increases cerebral blood volume and further elevates ICP. They also impair cerebral autoregulation. * **Ketamine:** Traditionally, Ketamine is contraindicated in patients with high ICP because it acts as a cerebral vasodilator, increasing CBF and ICP. It also increases CMRO2. (Note: While modern studies suggest it may be used with controlled ventilation, it remains the "wrong" answer for standard MCQ exams). **High-Yield Clinical Pearls for NEET-PG:** * **Inverse Steal Phenomenon (Robin Hood Effect):** Barbiturates like Thiopentone cause vasoconstriction in normal brain tissue, shunting blood toward ischemic areas where vessels are already maximally dilated. * **Propofol & Etomidate:** Both also decrease CBF, CMRO2, and ICP, making them safe alternatives to Thiopentone. * **CPP Formula:** $CPP = MAP - ICP$. To maintain brain perfusion, we must either increase Mean Arterial Pressure (MAP) or decrease ICP. * **Drug of Choice for Induction in Head Injury:** Thiopentone (if hemodynamically stable) or Propofol.

Question 14: Which of the following drugs does not affect the absorption and secretion of cerebrospinal fluid?

A. Halothane
B. Nitrous oxide (Correct Answer)
C. Ketamine
D. Thiopentone sodium

Explanation: The dynamics of Cerebrospinal Fluid (CSF) are governed by its rate of production (secretion) and its rate of reabsorption. Most anesthetic agents alter these parameters, which is a critical consideration in neuroanesthesia for managing intracranial pressure (ICP). **Explanation of the Correct Answer:** **Nitrous Oxide (N₂O)** is the correct answer because it has **no significant effect** on either the production or the reabsorption of CSF. While it is a potent cerebral vasodilator (which can increase cerebral blood volume), it remains neutral regarding CSF kinetics. **Analysis of Incorrect Options:** * **Halothane:** This volatile anesthetic **increases the resistance** to CSF reabsorption and may also increase production. This dual effect contributes to a significant rise in ICP, making it less favorable for patients with space-occupying lesions. * **Ketamine:** It is known to **increase the rate of CSF production** without significantly affecting reabsorption. This, combined with its vasodilatory effect, leads to an increase in ICP. * **Thiopentone Sodium:** Barbiturates like thiopentone **decrease the rate of CSF production**. By reducing cerebral metabolic rate (CMRO₂) and cerebral blood flow, they are traditionally used for "brain protection" and to lower ICP. **High-Yield Clinical Pearls for NEET-PG:** * **Etomidate and Propofol:** Both decrease the rate of CSF production, similar to thiopentone. * **Acetazolamide and Furosemide:** These are non-anesthetic drugs frequently tested; both **decrease** CSF production. * **Isoflurane:** Unique among volatiles as it **facilitates (increases) CSF reabsorption**, making it a preferred volatile agent in neurosurgery compared to Halothane. * **Summary Rule:** Most intravenous induction agents (except Ketamine) decrease CSF production, while most volatile agents (except Isoflurane) increase resistance to reabsorption.

Question 15: A patient has increased intracranial tension. Which of the following anesthetic agents is safe to use?

A. Ketamine
B. Thiopentone (Correct Answer)
C. Halothane
D. Ether

Explanation: **Explanation:** In neuroanesthesia, the primary goal for patients with increased intracranial pressure (ICP) is to maintain a balance between **Cerebral Blood Flow (CBF)** and **Cerebral Metabolic Rate of Oxygen (CMRO₂)**. **Why Thiopentone is the Correct Answer:** Thiopentone (a barbiturate) is considered the "gold standard" for neuroprotection in patients with raised ICP. It causes **potent cerebral vasoconstriction**, which leads to a significant decrease in CBF and Cerebral Blood Volume (CBV), thereby **lowering ICP**. Crucially, it also decreases CMRO₂, providing a protective effect to the brain during periods of potential ischemia. **Why the Other Options are Incorrect:** * **Ketamine:** Traditionally contraindicated in raised ICP because it is a potent cerebral vasodilator that increases CBF, CBV, and ICP. It also increases sympathetic outflow. * **Halothane:** Among all volatile anesthetics, halothane causes the most significant **vasodilation** of cerebral vessels. This leads to a massive increase in CBF and ICP, making it dangerous for neurosurgical patients. * **Ether:** Similar to halothane, ether causes cerebral vasodilation and increases ICP; it is also obsolete in modern practice due to its flammability and side-effect profile. **High-Yield Clinical Pearls for NEET-PG:** * **Inverse Steal Phenomenon (Robin Hood Effect):** Thiopentone constricts vessels in healthy brain tissue, diverting blood flow to ischemic areas where vessels are already maximally dilated. * **Propofol:** Like Thiopentone, it decreases CMRO₂ and ICP, making it another safe choice for induction. * **Etomidate:** Safe for ICP but may cause adrenal suppression. * **Nitrous Oxide ($N_2O$):** Can increase ICP and should be avoided if there is a risk of pneumocephalus.

Question 16: Cerebral metabolism and O2 consumption are increased by which of the following agents?

A. Propofol
B. Ketamine (Correct Answer)
C. Atracurium
D. Fentanyl

Explanation: **Explanation:** The correct answer is **Ketamine**. **1. Why Ketamine is Correct:** Most intravenous anesthetics are "cerebral protectants" because they cause **cerebral vasoconstriction**, which leads to a decrease in Cerebral Blood Flow (CBF), Cerebral Metabolic Rate of Oxygen (CMRO2), and Intracranial Pressure (ICP). **Ketamine is the notable exception.** It is a potent cerebral vasodilator that **increases CMRO2**, CBF, and ICP. It achieves this through sympathetic stimulation and neuronal activation, making it generally contraindicated in patients with space-occupying lesions or head injuries where intracranial compliance is compromised. **2. Why the Other Options are Incorrect:** * **Propofol (Option A):** This is the gold standard for neuro-anesthesia. It causes a dose-dependent **decrease** in CMRO2 and CBF (coupling), leading to a significant reduction in ICP. * **Atracurium (Option C):** As a neuromuscular blocking agent, it does not cross the blood-brain barrier and has **no direct effect** on cerebral metabolism or oxygen consumption. * **Fentanyl (Option D):** Opioids generally cause a mild **decrease** or no change in CMRO2 and CBF, provided that ventilation is maintained (as hypercapnia from respiratory depression could indirectly increase ICP). **High-Yield Clinical Pearls for NEET-PG:** * **The "Rule of Exceptions":** While almost all IV anesthetics decrease CMRO2/CBF, **Ketamine** increases them. While almost all Inhalational agents increase CBF (vasodilation), they decrease CMRO2 (uncoupling). * **Etomidate:** Also decreases CMRO2 and ICP, making it useful for induction in hemodynamically unstable neurosurgical patients. * **Thiopentone:** Historically used for "brain protection" during focal ischemia because it significantly reduces CMRO2 until the EEG becomes isoelectric.

Question 17: Which IV anesthetic causes increased cerebral blood flow and cerebral metabolic rate?

A. Thiopentone
B. Etomidate
C. Ketamine (Correct Answer)
D. Propofol

Explanation: **Explanation** In neuroanesthesia, the relationship between Cerebral Blood Flow (CBF) and the Cerebral Metabolic Rate of Oxygen consumption ($CMRO_2$) is critical. Most intravenous anesthetics exhibit **"flow-metabolism coupling,"** where a decrease in brain activity leads to a proportional decrease in blood flow. **Ketamine (The Correct Answer):** Ketamine is the unique exception among IV induction agents. It acts as a potent cerebral vasodilator, leading to a significant **increase in CBF** (by 60-80%). Simultaneously, it **increases $CMRO_2$** due to sympathetic stimulation and neuronal activation in certain brain regions. This combination can lead to a rise in **Intracranial Pressure (ICP)**, making it traditionally contraindicated in patients with space-occupying lesions or head injuries (though this is relative if the patient is ventilated). **Why the others are incorrect:** * **Thiopentone:** A potent cerebral vasoconstrictor that significantly reduces both $CMRO_2$ and CBF. It is often used for "brain protection" during focal ischemia. * **Etomidate:** Decreases $CMRO_2$ and CBF while maintaining hemodynamic stability. It is preferred for induction in patients with limited cardiac reserve. * **Propofol:** Causes a dose-dependent reduction in $CMRO_2$ and CBF, leading to a decrease in ICP. **High-Yield Clinical Pearls for NEET-PG:** * **The "Inverse Steal" (Robin Hood) Phenomenon:** Thiopentone and Propofol cause vasoconstriction in healthy brain tissue, shunting blood toward ischemic areas (where vessels are already maximally dilated). * **Ketamine & IOP:** Ketamine also increases Intraocular Pressure (IOP), unlike most other induction agents. * **Drug of Choice for ICP:** Thiopentone or Propofol are preferred when the goal is to reduce ICP.

Question 18: Which of the following pharmacologic agents increases cerebral oxygen consumption?

A. Propofol
B. Ketamine (Correct Answer)
C. Thiopentone
D. Alfentanyl

Explanation: ### Explanation The correct answer is **Ketamine**. #### 1. Why Ketamine is Correct Ketamine is a unique intravenous anesthetic that acts as an NMDA receptor antagonist. Unlike most other induction agents, Ketamine causes **cerebral vasodilation**, which leads to an increase in Cerebral Blood Flow (CBF). This is coupled with an **increase in Cerebral Metabolic Rate of Oxygen (CMRO2)**. Because it increases both CMRO2 and intracranial pressure (ICP), it is traditionally avoided in patients with space-occupying lesions or head injuries, though this is debated when ventilation is controlled. #### 2. Why the Other Options are Incorrect * **Propofol (Option A):** A potent hypnotic that causes **cerebral vasoconstriction**. It significantly **decreases CMRO2**, CBF, and ICP. It is often used for "brain protection." * **Thiopentone (Option C):** A barbiturate that is the gold standard for decreasing cerebral metabolism. It produces a dose-dependent **reduction in CMRO2** (up to 50%) and is used to provide neuroprotection during focal ischemia. * **Alfentanyl (Option D):** Like most opioids, Alfentanyl generally causes a **mild decrease or no change** in CMRO2 and CBF, provided that ventilation is maintained and $CO_2$ levels do not rise. #### 3. High-Yield Clinical Pearls for NEET-PG * **The "Coupling" Rule:** Most anesthetics (Propofol, Barbiturates, Etomidate) **couple** a decrease in CMRO2 with a decrease in CBF. Ketamine is the exception that increases both. * **Inhalational Agents:** These cause **"uncoupling"**—they decrease CMRO2 but increase CBF (due to vasodilation). * **Etomidate:** Decreases CMRO2 and CBF but is associated with **myoclonus** and adrenocortical suppression. * **Nitrous Oxide ($N_2O$):** Also increases CMRO2 and CBF, similar to Ketamine.

Question 19: Intracranial pressure is increased by which of the following anesthetic agents?

A. Thiopentone
B. Ketamine (Correct Answer)
C. Etomidate
D. Propofol

Explanation: **Explanation:** The regulation of Intracranial Pressure (ICP) in neuroanesthesia is primarily governed by the relationship between Cerebral Metabolic Rate of Oxygen (CMRO2) and Cerebral Blood Flow (CBF). **Why Ketamine is the Correct Answer:** Ketamine is a unique intravenous anesthetic that acts as a **potent cerebral vasodilator**. It increases CBF by 60–80% without a corresponding decrease in CMRO2. This increase in cerebral blood volume directly leads to an **elevation in ICP**. Additionally, ketamine can interfere with the reabsorption of cerebrospinal fluid (CSF), further contributing to intracranial hypertension. Therefore, it is traditionally contraindicated in patients with space-occupying lesions or head injuries. **Why Other Options are Incorrect:** * **Thiopentone, Propofol, and Etomidate** are all potent **cerebral vasoconstrictors**. * They cause **"Flow-Metabolism Coupling"**: they decrease CMRO2, which leads to a compensatory decrease in CBF. * By reducing cerebral blood volume, these agents effectively **lower ICP**, making them the drugs of choice for neurosurgical induction. Thiopentone, specifically, is known for its neuroprotective "burst suppression" on EEG. **High-Yield Clinical Pearls for NEET-PG:** * **The Exception:** While Ketamine increases ICP, recent evidence suggests this effect may be blunted if the patient is well-ventilated (maintaining normocapnia) and co-administered with benzodiazepines or propofol. * **Inhalational Agents:** All volatile anesthetics (Halothane > Isoflurane > Sevoflurane) increase ICP due to vasodilation, especially at doses >1 MAC. * **Drug of Choice:** **Propofol** is currently the preferred agent for neuro-induction due to its rapid onset and ability to reduce ICP and CMRO2. * **Etomidate** is preferred in hemodynamically unstable neurosurgical patients as it maintains Cerebral Perfusion Pressure (CPP) while lowering ICP.

Question 20: Which of the following increases cerebral oxygen consumption?

A. Propofol
B. Ketamine (Correct Answer)
C. Thiopentone
D. Alfentanil

Explanation: **Explanation:** The primary determinant of cerebral metabolic rate for oxygen (**CMRO2**) is neuronal activity. In neuroanesthesia, most intravenous anesthetics are "cerebro-protective" because they decrease both CMRO2 and Cerebral Blood Flow (CBF). **1. Why Ketamine is Correct:** Ketamine is a unique intravenous anesthetic (an NMDA receptor antagonist) that causes **dissociative anesthesia**. Unlike most other induction agents, it **increases CMRO2**, CBF, and intracranial pressure (ICP). It stimulates the sympathetic nervous system and increases neuronal activity in certain brain regions, leading to an increase in oxygen demand. **2. Why the Other Options are Incorrect:** * **Propofol (Option A):** A potent cerebral metabolic suppressant. It causes a dose-dependent decrease in CMRO2 and CBF, making it a preferred agent for neurosurgery. * **Thiopentone (Option C):** A barbiturate that significantly reduces CMRO2 by suppressing neuronal electrical activity. It is historically used for "brain protection" during focal ischemia. * **Alfentanil (Option D):** As an opioid, it generally causes a mild decrease or maintains stability in CMRO2 and CBF, provided ventilation is controlled and $PaCO_2$ remains normal. **Clinical Pearls for NEET-PG:** * **The "Rule of Exceptions":** Almost all IV anesthetics decrease CMRO2 and CBF; **Ketamine** is the notable exception. * **Inhalational Agents:** Most volatile anesthetics (like Isoflurane) **decrease CMRO2** but **increase CBF** (due to vasodilation), a phenomenon known as "uncoupling." * **Drug of Choice:** Propofol is the induction agent of choice in neurosurgery due to its rapid onset and ability to reduce ICP. * **Ketamine Caution:** Traditionally contraindicated in patients with space-occupying lesions or high ICP, though it may be used if the patient is adequately ventilated and co-administered with benzodiazepines/propofol.

Question 21: During surgery for aortic arch aneurysm under deep hypothermic circulatory arrest, which anesthetic agent administered prior to circulatory arrest also provides cerebral protection?

A. Etomidate
B. Thiopental sodium (Correct Answer)
C. Propofol
D. Ketamine

Explanation: **Explanation:** **Thiopental sodium** is the classic gold-standard induction agent for cerebral protection during procedures involving focal ischemia or circulatory arrest, such as aortic arch surgery. **Why Thiopental is Correct:** The primary mechanism for its neuroprotective effect is the **dose-dependent suppression of the Cerebral Metabolic Rate of Oxygen (CMRO2)**. Thiopental reduces neuronal electrical activity until the EEG becomes isoelectric (flat), effectively decreasing the brain’s oxygen demand by approximately 50%. This "metabolic depression" preserves high-energy phosphates and delays neuronal death during periods of zero or low blood flow. It also reduces cerebral blood volume and intracranial pressure (ICP). **Analysis of Incorrect Options:** * **Etomidate (A):** While it decreases CMRO2 and ICP, it is generally avoided in prolonged surgeries or high-stress states like aortic repair due to its side effect of **adrenocortical suppression** (inhibition of 11-beta-hydroxylase). * **Propofol (C):** Propofol does reduce CMRO2 and is used for neuroprotection; however, in the specific context of deep hypothermic circulatory arrest (DHCA), Thiopental has a longer history of proven efficacy and is the traditional "textbook" answer for this surgical scenario. * **Ketamine (D):** Historically contraindicated in neurosurgery because it **increases** cerebral blood flow, CMRO2, and ICP, making it the opposite of a neuroprotective agent in this context. **High-Yield Clinical Pearls for NEET-PG:** * **Barbiturate Coma:** Thiopental is used to induce "barbiturate coma" for refractory intracranial hypertension. * **Inverse Steal Phenomenon (Robin Hood Effect):** Thiopental causes vasoconstriction in healthy brain tissue, shunting blood toward ischemic areas where vessels are already maximally dilated. * **DHCA Temperature:** Deep hypothermia is typically defined as 18°C–20°C, which further reduces CMRO2 synergistically with Thiopental.

Question 22: Which muscle relaxant is known to increase intracranial pressure?

A. Mivacurium
B. Atracurium
C. Suxamethonium (Correct Answer)
D. Vecuronium

Explanation: **Explanation:** **Suxamethonium (Succinylcholine)** is the correct answer because it is the only muscle relaxant listed that consistently increases intracranial pressure (ICP). The underlying mechanism is attributed to a transient increase in cerebral blood flow (CBF) and cerebral metabolic rate of oxygen ($CMRO_2$). Additionally, the intense fasciculations caused by this depolarizing agent increase central venous pressure and muscle spindle activity, which further contributes to the rise in ICP. While this increase is usually modest and transient, it can be clinically significant in patients with severely reduced intracranial compliance. **Analysis of Incorrect Options:** * **Mivacurium & Atracurium:** These are benzylisoquinolinium non-depolarizing relaxants. While they can cause histamine release (which might lead to vasodilation and a theoretical rise in ICP), they do not directly increase ICP. In clinical practice, they are generally considered safe for neurosurgery if hypotension is avoided. * **Vecuronium:** This is an aminosteroid non-depolarizing relaxant. It is considered "neuro-neutral" as it has no effect on ICP, heart rate, or blood pressure, making it a preferred choice for maintenance in neuroanesthesia. **High-Yield Clinical Pearls for NEET-PG:** * **The "Pre-curarization" Technique:** The rise in ICP caused by Suxamethonium can be attenuated by administering a small "defasciculating" dose of a non-depolarizing muscle relaxant (e.g., Vecuronium) 3 minutes prior to induction. * **Rocunorium** is the preferred alternative to Suxamethonium for Rapid Sequence Induction (RSI) in neurosurgical emergencies where increased ICP is a concern. * **Pancuronium** should be avoided in neuroanesthesia because it causes tachycardia and hypertension, which can indirectly increase ICP.

Question 23: A 10-degree Celsius decrease in body temperature causes a decrease in cerebral metabolic rate by:

A. 10%
B. 30%
C. 50%
D. 70% (Correct Answer)

Explanation: **Explanation:** The relationship between body temperature and the **Cerebral Metabolic Rate of Oxygen (CMRO2)** is a fundamental concept in neuroanesthesia. Metabolism is a temperature-dependent chemical process; as temperature decreases, enzymatic activity and cellular energy requirements drop significantly. **Why 70% is correct:** The cerebral metabolic rate decreases by approximately **7% for every 1°C drop** in body temperature. This relationship is often described by the **Q10 coefficient**, which represents the change in a process when the temperature is altered by 10°C. In the brain, the Q10 is approximately 2 to 3. Mathematically, a 10°C decrease leads to a cumulative reduction of roughly **50% to 70%** in CMRO2. For NEET-PG purposes, 70% is the standard recognized value for a 10°C drop (from 37°C to 27°C). **Analysis of Incorrect Options:** * **A (10%) & B (30%):** These values are too low. A 10% or 30% reduction would correspond to a temperature drop of only 1.5°C to 4°C, respectively. * **C (50%):** While a 50% reduction is significant, it represents the lower end of the Q10 spectrum. Standard textbooks (like Miller’s Anesthesia) emphasize the 7% per degree rule, making 70% the more accurate high-yield answer for a full 10-degree shift. **High-Yield Clinical Pearls for NEET-PG:** 1. **Coupling:** In a normal brain, **Cerebral Blood Flow (CBF)** is "coupled" to CMRO2. Therefore, as hypothermia decreases CMRO2, CBF also decreases proportionally. 2. **Burst Suppression:** At temperatures below 20°C, the EEG may become isoelectric (flat), indicating a profound suppression of both functional and basal metabolism. 3. **Neuroprotection:** This physiological drop is the basis for using **Induced Hypothermia** during cardiac surgery or post-cardiac arrest to protect the brain from ischemic injury. 4. **Hyperthermia:** Conversely, fever increases CMRO2 and can exacerbate secondary brain injury in patients with head trauma or stroke.

Question 24: If pneumocephalus is created either by surgery or by performance of a pneumoencephalogram, it is suggested that nitrous oxide be avoided for how many days?

A. 4 days
B. 5 days
C. 6 days
D. 7 days (Correct Answer)

Explanation: **Explanation:** The correct answer is **7 days**. This recommendation is based on the physical properties of **Nitrous Oxide ($N_2O$)** and its interaction with closed gas spaces in the body. **1. Underlying Medical Concept:** Nitrous oxide is 34 times more soluble in blood than nitrogen. When $N_2O$ is administered, it diffuses from the blood into an air-filled cavity (like a pneumocephalus) much faster than nitrogen can diffuse out. This leads to a rapid increase in the volume or pressure of the air pocket. In the rigid intracranial vault, this expansion can cause **Tension Pneumocephalus**, leading to brain herniation or neurological deterioration. Studies on gas reabsorption show that it takes approximately **7 days** for intracranial air to be sufficiently absorbed to safely allow $N_2O$ use without risking expansion. **2. Analysis of Options:** * **Options A, B, and C (4, 5, 6 days):** These timeframes are insufficient. While some air may be absorbed, a significant volume often remains. Clinical guidelines and standard textbooks (like Miller’s Anesthesia) specify a 7-day safety window to ensure complete or near-complete resolution of the air pocket. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "Second Gas Effect" and "Diffusion Hypoxia"** are other key $N_2O$ concepts often tested. * **Contraindications for $N_2O$:** Pneumothorax (most common), air embolism, bowel obstruction, intraocular gas bubbles (post-vitrectomy), and middle ear surgeries. * **Post-Vitrectomy Rule:** If **SF6 (Sulfur hexafluoride)** was used in the eye, avoid $N_2O$ for **7–10 days**. If **C3F8 (Perfluoropropane)** was used, avoid it for **8 weeks**. * **Tension Pneumocephalus Sign:** Look for the **"Mount Fuji Sign"** on a CT scan (separation of frontal lobes by air).

Question 25: Which inhalational agent is used in patients with raised intracranial tension?

A. Enflurane
B. Isoflurane (Correct Answer)
C. Desflurane
D. Sevoflurane

Explanation: ### Explanation In neuroanesthesia, the primary goal is to maintain the balance between **Cerebral Blood Flow (CBF)** and **Cerebral Metabolic Rate of Oxygen (CMRO₂)** while preventing increases in **Intracranial Pressure (ICP)**. **Why Isoflurane is the Correct Answer:** Isoflurane is considered the gold standard inhalational agent for neurosurgery. It provides a potent reduction in CMRO₂ (neuroprotection) while having a relatively modest effect on cerebral vasodilation compared to older agents. Most importantly, at concentrations below 1 MAC, the decrease in CMRO₂ offsets the direct vasodilatory effect, resulting in minimal changes to CBF and ICP. It also preserves **cerebral autoregulation** better than other agents, making it the safest choice among the options for patients with raised ICT. **Analysis of Incorrect Options:** * **Enflurane:** It is strictly contraindicated in neurosurgery because it can induce **seizure-like activity** on EEG, which significantly increases CMRO₂ and ICP. * **Desflurane:** It can cause sympathetic stimulation and a rapid increase in CBF, especially during induction or dose escalation, which can lead to a dangerous rise in ICP. * **Sevoflurane:** While commonly used, it can impair cerebral autoregulation more than isoflurane at higher concentrations. However, in modern practice, it is a close second to isoflurane. In the context of standard PG exams, Isoflurane remains the classic "textbook" answer for raised ICT. **High-Yield Clinical Pearls for NEET-PG:** * **Ideal Agent:** **Propofol** (IV) is actually superior to all inhalational agents for raised ICT as it reduces both CBF and CMRO₂ (coupling). * **Nitrous Oxide (N₂O):** Should be avoided in neurosurgery as it increases CBF and can expand a pneumocephalus. * **Hyperventilation:** If an inhalational agent must be used, mild hypocapnia (PaCO₂ 30-35 mmHg) can blunt the vasodilatory response and help lower ICP.

Question 26: Brain dead individuals have all of the following features EXCEPT?

A. Dolls eye movement is absent
B. Oculo-vestibular reflex is absent
C. Only pain is preserved (Correct Answer)
D. Corneal reflex is absent

Explanation: ### Explanation **Concept Overview:** Brain death is defined as the irreversible loss of all functions of the entire brain, including the brainstem. To certify brain death, there must be a known irreversible cause, absence of confounding factors (like hypothermia or drug toxicity), and a **complete absence of brainstem reflexes**. **Why "Only pain is preserved" is the Correct Answer:** In a brain-dead individual, the brainstem is non-functional. Since the processing of painful stimuli occurs via the thalamus and cortex, and the motor response to pain is mediated through the brainstem or higher centers, a brain-dead patient will show **no purposeful or grimacing response to pain**. While spinal reflexes (like the knee jerk or plantar withdrawal) may persist because the spinal cord is separate from the brain, "pain" as a sensory-motor integration is lost. Therefore, the statement that pain is preserved is false. **Analysis of Incorrect Options:** * **A. Dolls eye movement (Oculocephalic reflex):** This reflex involves Cranial Nerves (CN) III, VI, and VIII and the brainstem pathways. In brain death, the eyes remain fixed in the midline when the head is turned (absent reflex). * **B. Oculo-vestibular reflex (Caloric test):** This is tested by irrigating the ear with ice-cold water. A normal response is nystagmus; in brain death, there is no eye movement, confirming brainstem failure. * **D. Corneal reflex:** This reflex involves CN V (sensory) and CN VII (motor). Its absence indicates midbrain and pontine dysfunction, a requirement for brain death diagnosis. **High-Yield Clinical Pearls for NEET-PG:** * **The Apnea Test** is the "Gold Standard" for confirming brain death. It is positive if the patient fails to breathe despite a $PaCO_2 \geq 60$ mmHg (or $20$ mmHg above baseline) and a $pH < 7.3$. * **Order of Reflex Loss:** Usually, cortical functions go first, followed by brainstem reflexes. * **Spinal Reflexes:** Presence of deep tendon reflexes or the "Lazarus sign" (spontaneous arm movements) does **not** rule out brain death, as these are mediated by the spinal cord. * **Prerequisites:** Core temperature must be $>36.5^\circ C$ and Systolic BP must be $>100$ mmHg before testing.

Question 27: A patient is scheduled for neurosurgery for posterior fossa tumor. During the surgery the BP crashes and Et CO2 suddenly decreases to zero. All are true regarding the condition leading to this catastrophe except:

A. Mill wheel murmur
B. High pressure in cerebral venous sinuses is a major risk factor (Correct Answer)
C. TEE is the most sensitive investigation step
D. Nitrous oxide accentuates the hemodynamic collapse

Explanation: ***High pressure in cerebral venous sinuses is a major risk factor*** - **Venous air embolism** (VAE) is a known complication of neurosurgery in the sitting position, where the surgical field is **above the level of the heart**. - In such cases, a **negative pressure gradient** between the surgical site and the heart allows air to be entrained into open veins, making **low or subatmospheric pressure in cerebral venous sinuses** a major risk factor, not high pressure. *Mill wheel murmur* - A **"mill wheel" murmur** (or "churning" sound) can sometimes be heard over the precordium when a large amount of air enters the right ventricle, indicating **venous air embolism**. - This is a classic, though not always present, clinical sign of a significant air embolism. *TEE is the most sensitive investigation step* - **Transesophageal echocardiography (TEE)** is indeed considered the **most sensitive monitoring technique** for detecting venous air embolism. - It can detect very small amounts of air within the heart before significant hemodynamic changes occur. *Nitrous oxide accentuates the hemodynamic collapse* - If a venous air embolism occurs, **nitrous oxide (N2O)** should be immediately discontinued because it can **expand the size of the air embolus**, especially if it crosses into the arterial circulation through a patent foramen ovale. - This expansion can worsen hemodynamic compromise and exacerbate ischemic injury.

Question 28: A patient is scheduled for neurosurgery for posterior fossa tumor. During the surgery the BP crashes and Et CO2 suddenly decreases to zero. What is the most likely diagnosis?

A. Venous air embolism (Correct Answer)
B. Trauma to respiratory center
C. Dislodgement of endotracheal tube
D. Wearing off effect of inhalation anesthesia

Explanation: ***Venous air embolism*** - Neurosurgery in the **posterior fossa** often involves the **sitting position**, which creates a hydrostatic gradient favoring air entrainment into open veins from the surgical field, leading to **venous air embolism (VAE)**. - VAE classically presents with a sudden decrease in **end-tidal CO2 (EtCO2)** due to increased dead space, along with **hypotension** (BP crash) from cardiovascular collapse. *Trauma to respiratory center* - While trauma to the brainstem's respiratory center could cause respiratory arrest, it would primarily lead to **cessation of respiration**, not a sudden drop to zero in EtCO2 with accompanying hypotension, unless combined with severe cardiovascular compromise. - The sudden onset of both **BP crash** and **zero EtCO2** is more indicative of an acute circulatory or pulmonary event. *Dislodgement of endotracheal tube* - A dislodged endotracheal tube would lead to a sudden decrease (**or absence**) of EtCO2, but primarily due to **ventilation failure**. - While it could cause some degree of hypotension from hypoxia, a complete **BP crash** to zero is less likely to be the primary and immediate result compared to the profound cardiovascular effects of a large air embolism. *Wearing off effect of inhalation anesthesia* - The "wearing off effect" of inhalation anesthesia would typically lead to the patient **waking up and becoming more responsive**, with an **increase in blood pressure and heart rate**, not a sudden drop to zero in EtCO2 and a BP crash. - This scenario describes a **catastrophic complication**, not a normal physiological response to anesthetic metabolism.

Question 29: A comatose patient after sustaining severe head injury has been admitted to the neurosurgical ICU. Which of the following parameters should ideally be maintained in this patient? 1. pCO2 = 4.5 - 5.0 kPa (33-38 mm Hg) 2. MAP = 80 - 90 mm of Hg 3. pO2 > 11 kPa (> 80 mm Hg) 4. Na+ < 130 meq/L

A. 2, 3 and 4
B. 1, 2 and 4
C. 1, 3 and 4
D. 1, 2 and 3 (Correct Answer)

Explanation: ***1, 2 and 3*** - Maintaining **pCO2 between 4.5-5.0 kPa (33-38 mmHg)** helps optimize cerebral blood flow; values outside this range can cause vasoconstriction or vasodilation, affecting intracranial pressure (ICP). - A **mean arterial pressure (MAP) of 80-90 mmHg** ensures adequate cerebral perfusion pressure (CPP) and minimizes the risk of secondary brain injury from ischemia. - An **arterial partial pressure of oxygen (pO2) above 11 kPa (>80 mmHg)** is crucial to prevent cerebral hypoxia, which can exacerbate brain damage in severely injured patients. *2, 3 and 4* - This option correctly identifies the importance of maintaining adequate MAP and pO2 but incorrectly suggests a low sodium level. - A low **serum sodium (Na+) below 130 mEq/L (hyponatremia)** should be avoided in severe head injury as it can worsen cerebral edema and increase ICP. *1, 2 and 4* - While maintaining pCO2 and MAP within target ranges is essential, a **sodium level below 130 mEq/L (hyponatremia)** is detrimental and not an ideal parameter to maintain. - Hyponatremia can lead to further **brain swelling** and increased intracranial pressure. *1, 3 and 4* - This combination correctly identifies ideal pCO2 and pO2 targets but incorrectly includes **hyponatremia (Na+ < 130 mEq/L)** as a desirable parameter. - Severe hyponatremia can cause significant neurological complications including **seizures** and worsening cerebral edema.

Question 30: Anesthetic agent contraindicated in raised ICT is?

A. Thiopentone
B. Etomidate
C. Ketamine (Correct Answer)
D. Sevoflurane

Explanation: ***Ketamine*** - **Ketamine** is known to increase **cerebral blood flow** and metabolic rate, which can lead to a significant increase in **intracranial pressure (ICP)**. - This effect makes **ketamine** contraindicated in situations of elevated ICP, as it can worsen neurological outcomes. *Thiopentone* - **Thiopentone** is a barbiturate that typically causes a dose-dependent **decrease in cerebral blood flow** and **metabolic rate**, leading to a *reduction* in ICP. - It is often used to *lower* ICP in neurosurgical settings rather than being contraindicated. *Etomidate* - **Etomidate** also causes a **reduction in cerebral blood flow** and **cerebral metabolic rate**, leading to a *decrease* in ICP. - It is considered a relatively **hemodynamically stable** induction agent, making it suitable in many cases with neurological concerns. *Sevoflurane* - **Sevoflurane**, an inhaled anesthetic, can cause **cerebral vasodilation** at higher concentrations, potentially *increasing* ICP. - However, this effect is often *attenuated* by concurrent hyperventilation, and its overall impact on ICP is less pronounced than **ketamine's** and often manageable.

Question 31: Which of the following is the best cerebroprotective drug?

A. Propofol
B. Thiopentone (Correct Answer)
C. Etomidate
D. Ketamine

Explanation: ***Thiopentone*** - **Thiopentone** is a barbiturate that can significantly reduce cerebral metabolic rate for oxygen (**CMRO2**) and cerebral blood flow (**CBF**), leading to a reduction in intracranial pressure (**ICP**). - It achieves neuroprotection by decreasing brain metabolism, scavenging free radicals, and stabilizing neuronal membranes. *Propofol* - **Propofol** also reduces **CMRO2** and **CBF**, thus decreasing **ICP**, but its neuroprotective effects are less profound and consistent compared to barbiturates like thiopentone. - While it has some neuroprotective properties, such as antioxidant effects, it is not considered the **best** cerebroprotective agent, especially in severe cases where maximum cerebral protection is needed. *Etomidate* - **Etomidate** is known for its minimal cardiovascular effects and its ability to reduce **CMRO2** and **CBF**, which can lower **ICP**. - However, its use is limited by its potential to cause adrenal suppression with prolonged or repeated administration, making it less suitable for continuous cerebroprotection. *Ketamine* - **Ketamine** typically increases **CBF** and **CMRO2**, which can lead to an increase in **ICP**, making it generally unsuitable as a cerebroprotective agent in patients with elevated ICP or acute cerebral injury. - While it has analgesic and dissociative properties, its impact on cerebral hemodynamics often contraindicates its use in situations requiring brain protection.

Question 32: Thiopentone has cerebroprotective effect because of –

A. Decrease cerebral metabolism (Correct Answer)
B. Calcium channel blockage
C. Reduction of vasospasm
D. Free radical removal

Explanation: ***Decrease cerebral metabolism*** - Thiopentone significantly **reduces cerebral metabolic rate** of oxygen consumption (CMRO2) by depressing neuronal activity. - This reduction in metabolic demand makes the brain more resilient to **ischemic injury**, offering a cerebroprotective effect. *Calcium channel blockage* - While some anesthetic agents have calcium channel blocking properties, this is not the primary mechanism behind thiopentone's **cerebroprotective effects**. - Calcium channel blockers are more commonly used for conditions like **hypertension** or certain arrhythmias. *Reduction of vasospasm* - Thiopentone does not primarily act as a **vasodilator** or antispasmodic agent to directly reduce cerebral vasospasm. - Vasospasm reduction is often targeted by therapies like **nimodipine** in specific conditions like subarachnoid hemorrhage. *Free radical removal* - Although **barbiturates** may have some antioxidant properties, free radical scavenging is not the main mechanism for thiopentone's significant cerebroprotection. - The cerebroprotective effect is predominantly due to its **metabolic suppression**.

Question 33: All of the following decrease cerebral blood flow and intracranial pressure except:

A. Ketamine (Correct Answer)
B. Thiopentone
C. Propofol
D. Etomidate

Explanation: ***Ketamine*** - Ketamine is an exception as it is known to **increase cerebral blood flow (CBF)** and **intracranial pressure (ICP)** due to its dissociative anesthetic properties. - It causes cerebral vasodilation and increased cerebral metabolic rate, making it generally avoided in patients with elevated ICP or head trauma. *Thiopentone* - Thiopentone (a barbiturate) is a potent cerebral vasoconstrictor that **decreases cerebral blood flow (CBF)** and **intracranial pressure (ICP)**. - It achieves this by reducing the cerebral metabolic rate of oxygen consumption (CMRO2), thus coupling metabolism and flow. *Propofol* - Propofol significantly **reduces cerebral blood flow (CBF)** and **intracranial pressure (ICP)** by causing widespread cerebral vasoconstriction. - Its rapid onset and offset, along with its neuroprotective properties, make it a favorable agent for neuroanesthesia. *Etomidate* - Etomidate is an imidazole derivative that causes a significant **reduction in cerebral blood flow (CBF)** and **intracranial pressure (ICP)** comparable to barbiturates. - It achieves this by reducing cerebral metabolic rate and causing cerebral vasoconstriction, without significantly altering systemic hemodynamics.

Question 34: Increased intracranial pressure occurs with:

A. Succinylcholine (Correct Answer)
B. None of the options
C. Rocuronium
D. Vecuronium

Explanation: ***Succinylcholine*** - **Succinylcholine** is known to cause a transient increase in **intracranial pressure (ICP)** due to its fasciculations, which can increase cerebral blood flow and metabolic demand. - This effect is particularly relevant in patients with pre-existing elevated ICP or those at risk of brain herniation. *None of the options* - This option is incorrect because **succinylcholine** does indeed cause an increase in ICP, making one of the listed drugs relevant. *Rocuronium* - **Rocuronium** is a **nondepolarizing neuromuscular blocker** and typically does not significantly increase ICP; it is often considered safe for use in patients with intracranial pathology. - Its mechanism of action does not involve muscle fasciculations, which are the primary reason for ICP elevation with succinylcholine. *Vecuronium* - **Vecuronium** is also a **nondepolarizing neuromuscular blocker** and, like rocuronium, does not typically cause a significant increase in ICP. - It works by blocking acetylcholine receptors at the neuromuscular junction without stimulating them, thus avoiding the fasciculations seen with succinylcholine.

Question 35: Which anaesthetic agent increases intracranial pressure among the following

A. Lignocaine
B. Sevoflurane (Correct Answer)
C. Propofol
D. Thiopentone

Explanation: ***Sevoflurane*** - **Volatile anesthetics** like sevoflurane are potent **cerebral vasodilators**, which increases **cerebral blood flow** and consequently **intracranial pressure** (ICP). - This effect is dose-dependent and can be particularly concerning in patients with pre-existing elevated ICP. *Lignocaine* - **Lidocaine** (Lignocaine) is a local anesthetic that, when administered intravenously, can actually **decrease ICP** due to its ability to suppress cerebral metabolism and cerebral blood flow. - It works by stabilizing neuronal membranes and inhibiting the conduction of nerve impulses, thus reducing activity in the central nervous system. *Propofol* - **Propofol** significantly **reduces cerebral blood flow** and **cerebral metabolic rate**, leading to a decrease in **intracranial pressure**. - Its rapid onset and offset properties, coupled with its neuroprotective effects, make it a preferred agent for induction and maintenance in neurosurgical anesthesia. *Thiopentone* - **Thiopentone**, a barbiturate, is known for its ability to **decrease cerebral blood flow** and **cerebral metabolic rate**, thereby effectively **reducing intracranial pressure**. - Its potent cerebral vasoconstrictive effects are utilized in acute neurological emergencies to manage elevated ICP.

Question 36: Which of the following anaesthetic agents causes a rise in the Intracranial pressure:

A. Propofol.
B. Thiopentone sodium.
C. Lignocaine.
D. Sevoflurane. (Correct Answer)

Explanation: ***Sevoflurane*** - **Sevoflurane** is an inhaled anesthetic that causes cerebral vasodilation, leading to an increase in **cerebral blood flow** and consequently, a rise in **intracranial pressure (ICP)**. - This effect is dose-dependent and can be attenuated by maintaining normocapnia or mild hypocapnia to cause cerebral vasoconstriction. *Propofol* - **Propofol** is an intravenous anesthetic that typically causes a dose-dependent decrease in **cerebral metabolic rate** and **cerebral blood flow**, leading to a reduction in **intracranial pressure (ICP)**. - It is often used for induction and maintenance of anesthesia in critically ill patients with elevated ICP due to its favorable cerebral effects. *Thiopentone sodium* - **Thiopentone sodium** (thiopental) is a barbiturate that significantly reduces **cerebral metabolic rate** and **cerebral blood flow**, thereby **decreasing intracranial pressure (ICP)**. - It is used in neuroanesthesia to protect the brain and lower ICP, particularly in cases of head injury or intracranial hemorrhage. *Lignocaine* - **Lignocaine** (lidocaine) is a local anesthetic that, when administered intravenously, can decrease **cerebral metabolic rate** and **cerebral blood flow**, leading to a **reduction in intracranial pressure (ICP)**. - It is sometimes used as an adjunct in neuroanesthesia for its cerebral protective effects and to blunt airway reflexes, which can otherwise transiently increase ICP.

Question 37: Which of the following anesthetic agents may have cerebroprotective effect:

A. Ketamine
B. Etomidate
C. Barbiturates
D. All show cerebroprotective effect (Correct Answer)

Explanation: ***All show cerebroprotective effect*** - **Barbiturates**, such as **thiopental**, are known for their profound **cerebroprotective effects** by significantly reducing **cerebral metabolic rate** and **intracranial pressure (ICP)**, particularly beneficial during neurological insults. - **Ketamine** can maintain **cerebral blood flow (CBF)** and **metabolic activity**, potentially offering protection against **ischemic damage** in certain contexts. - **Etomidate** is a short-acting hypnotic agent that can effectively lower **cerebral metabolic rate for oxygen (CMRO2)** and ICP, making it useful for neurosurgical procedures. *Ketamine* - While it can be considered **cerebroprotective** in some situations, particularly by maintaining **cerebral blood flow** and thus oxygen delivery, it is typically associated with increased **cerebral blood flow** and **intracranial pressure** which can be detrimental in cases of head injury or space-occupying lesions. - Its effects on **cerebral metabolism** are complex; while it can decrease overall **metabolic demand**, it can paradoxically increase CMRO2 in certain brain regions. *Etomidate* - **Etomidate** is excellent at reducing **cerebral metabolic rate** and **intracranial pressure**, thus offering protection against **ischemic damage**. - Its **cerebroprotective** properties are primarily linked to its ability to decrease global brain metabolic activity without significantly changing **cerebral blood flow**. *Barbiturates* - **Barbiturates** induce a **dose-dependent reduction** in **cerebral metabolic rate of oxygen (CMRO2)** and **cerebral blood flow (CBF)**, leading to a significant decrease in **intracranial pressure (ICP)**. - This property makes them highly valuable for **cerebroprotection** in conditions like **traumatic brain injury** or **ischemic stroke**.

Question 38: Which of the following drugs is contraindicated in a patient with raised intracranial pressure ?

A. Ketamine (Correct Answer)
B. Midazolam
C. Propofol
D. Thiopentone

Explanation: ***Ketamine*** - **Ketamine** typically causes an increase in **cerebral blood flow** and **intracranial pressure (ICP)**, making it contraindicated in patients with raised ICP. - This effect is due to its action as a **dissociative anesthetic** which can lead to cerebral vasodilation. *Midazolam* - **Midazolam**, a benzodiazepine, can decrease **cerebral metabolic rate** and **cerebral blood flow**, thereby reducing ICP, making it a suitable option for sedation in patients with raised ICP. - It provides **sedation** and **anxiolysis** without significantly increasing ICP. *Propofol* - **Propofol** is a common choice for sedation in patients with raised ICP because it significantly reduces **cerebral blood flow**, **cerebral metabolic rate**, and thus **intracranial pressure**. - Its rapid onset and offset allow for precise control of depth of sedation and neurological assessment. *Thiopentone* - **Thiopentone**, a barbiturate, effectively reduces **cerebral blood flow** and **cerebral metabolic rate**, leading to a decrease in **intracranial pressure**. - It is often used for inducing anesthesia and as a neuroprotective agent in situations with acute brain injury.

Question 39: Which one of the following increases intracranial tension

A. Thiopentone
B. Ketamine (Correct Answer)
C. Propofol
D. Halothane

Explanation: ***Ketamine*** - Ketamine causes a dose-dependent increase in **cerebral blood flow (CBF)** and **intracranial pressure (ICP)**, which is why it is generally avoided in patients with increased intracranial tension. - This effect is mediated by its mechanism of action as an **NMDA receptor antagonist**, which can indirectly lead to cerebral vasodilation. *Thiopentone* - Thiopentone, a **barbiturate**, decreases **cerebral metabolic rate of oxygen (CMRO2)**, leading to a reduction in **cerebral blood flow (CBF)** and consequently, a decrease in **intracranial pressure (ICP)**. - It is often used to treat elevated ICP, providing **neuroprotection** by reducing brain activity. *Propofol* - Propofol significantly reduces **cerebral blood flow (CBF)** and **cerebral metabolic rate of oxygen (CMRO2)**, leading to a decrease in **intracranial pressure (ICP)**. - Its rapid onset and offset, coupled with its ability to lower ICP, make it a favorable agent for sedation in neurosurgical patients. *Halothane* - While halothane can cause **cerebral vasodilation** and an increase in **cerebral blood flow (CBF)**, leading to increased ICP, its use has largely been replaced by newer inhalational agents like isoflurane and sevoflurane, which have less pronounced effects on ICP or even decrease it. - Its propensity for inducing dose-dependent **cerebral vasodilation** when used at higher concentrations makes it less ideal in situations where ICP is a concern.

Question 40: Air embolism in neural surgery maximum in which position:

A. Left lateral
B. Sitting (Correct Answer)
C. Supine
D. Trendelenburg

Explanation: ***Sitting*** - In the **sitting position** for neural surgery, the surgical field, particularly the head, is often elevated above the heart. This creates a **negative pressure gradient** in the venous system, increasing the risk of air entrainment if a vein is opened and air is allowed to enter. - The **higher elevation of the operative site** relative to the right atrium significantly increases the likelihood of air being sucked into open veins. *Left lateral* - While air embolism can occur in any position, the **left lateral position** does not inherently create the same significant negative pressure gradient as the sitting position in the surgical field relative to the heart. - The patient's body is positioned on its side, which can help in certain surgical approaches but typically does not elevate the head as dramatically as the sitting position. *Supine* - In the **supine position**, the patient is lying on their back, and the operative field (head or spine) is generally at or below the level of the heart, reducing the pressure gradient that favors air entrainment. - This position typically offers a **lower risk of air embolism** compared to the sitting position due to less negative pressure in exposed veins. *Trendelenburg* - The **Trendelenburg position** involves placing the patient head-down and feet-up, which increases venous pressure in the upper body and head. - This position actively works against the negative pressure gradient, thereby **reducing the risk of air entrainment** into open veins through increased venous pressure.

Question 41: Anesthetic agent (s) safe to use in ICP

A. Ketamine
B. Thiopentone (Correct Answer)
C. Halothane
D. Ether

Explanation: ***Thiopentone*** - **Thiopentone** is an ultrashort-acting barbiturate that reduces cerebral blood flow and cerebral metabolic rate, leading to a decrease in **intracranial pressure (ICP)**. - It rapidly depresses brain activity, which directly lowers the demand for oxygen and nutrients, thus decreasing the blood volume within the cranium. *Ketamine* - **Ketamine** is known to increase cerebral blood flow and cerebral metabolic rate, which can lead to an undesirable **increase in ICP**. - It causes cerebral vasodilation, which in patients with compromised intracranial compliance can worsen cerebral edema and raise ICP. *Halothane* - **Halothane** is a potent volatile anesthetic that causes significant **cerebral vasodilation**, leading to an increase in cerebral blood flow and potentially elevated **ICP**. - Its use has largely declined due to its dose-dependent cerebral vasodilation and potential for myocardial depression. *Ether* - **Ether** is an old inhaled anesthetic agent that causes marked **cerebral vasodilation** and increased cerebral blood flow, thereby elevating **ICP**. - It also has a slow onset and offset of action and is highly flammable, making it unsuitable for modern anesthesia, especially in neurosurgical contexts.

Question 42: Intracranial pressure is increased by

A. Ketamine (Correct Answer)
B. Thiopentone
C. Ether
D. Halothane

Explanation: ***Ketamine*** - **Ketamine** is known to increase **cerebral blood flow** and thus intracranial pressure, making it generally avoided in patients with elevated ICP. - This effect is mediated by its influence on **cerebral metabolism** and **vasodilation**. *Thiopentone* - **Thiopentone** is a barbiturate that typically **reduces cerebral blood flow** and **metabolic rate**, thereby decreasing intracranial pressure. - It is often used for **neuroprotection** and to control elevated ICP due to its vasoconstrictive properties. *Ether* - **Ether** is an older inhalational anesthetic that generally causes **cerebral vasodilation**, which can lead to an increase in intracranial pressure. - While it does increase ICP, it is **no longer commonly used** in modern anesthesia practice due to its side effects and flammability. *Halothane* - **Halothane** is an inhalational anesthetic that causes dose-dependent **cerebral vasodilation**, leading to an increase in intracranial pressure. - Its use has largely been replaced by newer agents (**isoflurane, sevoflurane**) which have a more favorable ICP profile or are less likely to cause hepatic toxicity.

Question 43: Which inhalational agent increases intracranial pressure most significantly?

A. Halothane (Correct Answer)
B. Sevoflurane
C. Isoflurane
D. Desflurane

Explanation: ***Halothane*** - **Halothane** causes a greater increase in **cerebral blood flow** and thus **intracranial pressure (ICP)** compared to newer volatile anesthetics due to its more potent cerebral vasodilation. - Its use has largely declined due to concerns about its effects on ICP and potential for **hepatotoxicity**. *Sevoflurane* - While sevoflurane can cause **cerebral vasodilation** and increase ICP, its effect is generally less pronounced than halothane, especially when normocapnia is maintained. - It is often favored in neuroanesthesia due to its rapid onset and offset, allowing for quicker adjustments in anesthetic depth. *Isoflurane* - Isoflurane causes less cerebral vasodilation and a smaller increase in ICP compared to halothane, particularly at lower concentrations. - It maintains **cerebral vascular autoregulation** better than halothane, helping to preserve a more stable ICP. *Desflurane* - Desflurane also causes cerebral vasodilation and can increase ICP, but its effect is typically less significant than halothane. - Rapid increases in desflurane concentration can lead to sympathetic stimulation and transient increases in blood pressure, which can indirectly affect ICP.

Question 44: A 70-year-old male with a history of Parkinson's disease is scheduled for a hip replacement. Which anesthetic agent should be avoided due to its potential adverse effects on Parkinsonian symptoms?

A. Ketamine
B. Propofol
C. Midazolam
D. Droperidol (Correct Answer)

Explanation: ***Droperidol*** - **Droperidol** is a **dopamine receptor antagonist** and can worsen parkinsonian symptoms by further depleting existing dopamine levels or blocking its effects. - Patients with Parkinson's disease already have a deficiency in **dopamine**, and medications that block dopamine receptors should be avoided. *Ketamine* - **Ketamine** is a dissociative anesthetic that acts primarily as an **NMDA receptor antagonist**. - It does not directly interfere with dopamine pathways in a way that would exacerbate Parkinson's disease. *Propofol* - **Propofol** is a short-acting intravenous anesthetic that primarily acts on **GABA-A receptors**. - It has no known adverse effects on **dopaminergic pathways** or Parkinson's disease symptoms. *Midazolam* - **Midazolam** is a benzodiazepine that enhances the effects of **GABA** at the **GABA-A receptor**. - It is used for sedation and anxiety relief and does not typically affect Parkinson's disease symptoms.

Question 45: In a patient undergoing spine surgery, which monitoring modality is essential for the early detection of spinal cord ischemia?

A. Electroencephalography
B. Somatosensory evoked potentials (Correct Answer)
C. Pulse oximetry
D. Capnography

Explanation: ***Somatosensory evoked potentials*** - **Somatosensory Evoked Potentials (SSEPs)** monitor the integrity of the **dorsal column-medial lemniscus pathway**, which is sensitive to spinal cord ischemia. - A significant decrease in amplitude or increase in latency of SSEPs can indicate **ischemia** or **mechanical injury** to the spinal cord during surgery, allowing for timely intervention. *Electroencephalography* - **Electroencephalography (EEG)** primarily monitors **cortical activity** and is essential for detecting cerebral ischemia or seizure activity, but it does not directly monitor spinal cord function. - While global ischemia can affect both brain and spinal cord, EEG is not specific for early detection of **spinal cord-specific ischemia**. *Pulse oximetry* - **Pulse oximetry** measures **peripheral oxygen saturation** and pulse rate, reflecting systemic oxygenation. - It does not provide direct information about the **spinal cord's perfusion** or neural integrity. *Capnography* - **Capnography** measures the **partial pressure of carbon dioxide in exhaled breath**, primarily used for monitoring ventilation and confirming endotracheal tube placement. - It offers no direct insight into the **spinal cord's neurological status** or blood supply.

Question 46: Which of the following agents is preferred for rapid sequence induction in a patient with suspected increased intracranial pressure?

A. Etomidate (Correct Answer)
B. Propofol
C. Thiopental
D. Ketamine

Explanation: ***Etomidate*** - **Etomidate** is preferred for rapid sequence induction in patients with suspected increased ICP because it provides rapid onset of **sedation and hypnosis** while maintaining **cardiovascular stability**. - It causes minimal changes in **heart rate** or **blood pressure**, which is crucial in patients who may be hemodynamically unstable from their injury or who are sensitive to changes in **cerebral perfusion pressure**. *Propofol* - While **propofol** reduces ICP, it can cause significant **hypotension** due to systemic vasodilation and myocardial depression. - This **hypotension** can compromise **cerebral perfusion pressure** in patients with already elevated ICP, potentially worsening outcomes. *Thiopental* - **Thiopental**, a barbiturate, effectively reduces ICP by decreasing cerebral metabolic rate and blood flow but can also lead to significant **hypotension**. - Its longer half-life compared to etomidate makes it less ideal for rapid sequence induction where quick recovery or titrated effects might be desired. *Ketamine* - Traditionally, **ketamine** was avoided in patients with increased ICP because it was thought to directly increase cerebral blood flow and ICP. - Although more recent data suggest it might be safe or even beneficial in some trauma settings, its potential to increase ICP makes it a less preferred first-line agent when increased ICP is suspected compared to etomidate.

Question 47: Which anesthetic agent is safe to use in patients with elevated intracranial pressure (ICP)?

A. Thiopentone (Correct Answer)
B. Halothane
C. Ketamine
D. Ether

Explanation: ***Thiopentone*** - **Thiopentone** is a barbiturate that **decreases cerebral blood flow** and **metabolic rate**, leading to a reduction in intracranial pressure (ICP). - Its rapid onset and short duration of action make it suitable for inducing anesthesia in patients with elevated ICP. *Halothane* - **Halothane** is a potent **vasodilator** that can increase cerebral blood flow and consequently **elevate intracranial pressure**, making it unsuitable. - It also has a **slow onset and offset**, which can be problematic in emergent situations involving ICP. *Ketamine* - **Ketamine** is known to significantly **increase cerebral blood flow** and **intracranial pressure**, making it generally contraindicated in patients with elevated ICP. - It can also cause **dissociative states** and **emergence delirium**, which can further complicate neurological assessment. *Ether* - **Ether** is an older anesthetic agent known to cause **significant cerebral vasodilation** and an **increase in intracranial pressure**. - It is **highly flammable** and rarely used in modern clinical practice due to its side effects and safety profile.

Question 48: Inhalational agent of choice for neurosurgery?

A. Halothane
B. Enflurane
C. Isoflurane (Correct Answer)
D. N2O

Explanation: ***Isoflurane*** - **Isoflurane** is preferred in neurosurgery due to its minimal impact on **cerebral blood flow** and **intracranial pressure (ICP)**, allowing cerebral autoregulation to be largely preserved. - It maintains **cerebral perfusion pressure** well and has a relatively fast onset and offset, facilitating neurological assessment post-operatively. *Halothane* - **Halothane** significantly increases **cerebral blood flow** and **intracranial pressure (ICP)**, which is undesirable in neurosurgical patients. - Its slow elimination can prolong recovery and neurological assessment, making it unsuitable for neurosurgery. *Enflurane* - **Enflurane** can cause central nervous system excitation and has been associated with **seizure activity** at higher concentrations, making it contraindicated in neurosurgical procedures. - Like halothane, it can also increase **cerebral blood flow** and **intracranial pressure**. *N2O* - **Nitrous oxide (N2O)** should be avoided in neurosurgery, especially if there's a risk of **intracranial air** or **pneumocephalus**, as it can expand air-filled spaces and increase ICP. - It also has a weak anesthetic effect and is often combined with other agents, but its cerebral vasodilatory properties can still be problematic.

Question 49: Which anesthetic agent is known to increase intracranial pressure in patients with head injuries?

A. Ketamine (Correct Answer)
B. Propofol
C. Etomidate
D. Ether

Explanation: ***Ketamine*** - **Ketamine** can cause a direct cerebral vasodilator effect, leading to increased cerebral blood flow and **intracranial pressure (ICP)**. - This effect makes it generally contraindicated in patients with acute head injuries or elevated ICP. *Propofol* - **Propofol** is known to decrease cerebral metabolic rate and cerebral blood flow, leading to a **reduction in ICP**. - It is often favored in neurosurgical settings for its ability to lower ICP and improve cerebral perfusion pressure. *Etomidate* - **Etomidate** is a short-acting hypnotic agent that can also cause a significant **reduction in ICP** due to decreased cerebral blood flow and metabolic rate. - It is commonly used for induction of anesthesia in patients with head injuries due to its hemodynamic stability. *Ether* - **Ether** (diethyl ether) is an older anesthetic agent that has largely been replaced due to its many side effects, including a tendency to **increase ICP**. - While it can increase ICP, its use in modern anesthetic practice is minimal, and ketamine is a more contemporary concern for this effect.

Practice by Chapter

Cerebral Physiology and Pathophysiology

Practice Questions

Anesthetics and Cerebral Blood Flow

Practice Questions

Intracranial Pressure Management

Practice Questions

Anesthesia for Supratentorial Craniotomy

Practice Questions

Anesthesia for Infratentorial Craniotomy

Practice Questions

Anesthesia for Traumatic Brain Injury

Practice Questions

Neuromonitoring Techniques

Practice Questions

Anesthesia for Spine Surgery

Practice Questions

Anesthesia for Neurovascular Procedures

Practice Questions

Awake Craniotomy

Practice Questions

Neuromuscular Disorders

Practice Questions

Postoperative Care in Neurosurgical Patients

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free